TSHA
NASDAQ · Biotechnology
Taysha Gene Therapies Inc
$6.71
+0.04 (+0.60%)
Open$6.64
Previous Close$6.67
Day High$6.78
Day Low$6.58
52W High$7.30
52W Low$1.85
Volume—
Avg Volume2.36M
Market Cap1.92B
P/E Ratio—
EPS$-0.34
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+807.0% upside
Current
$6.71
$6.71
Target
$60.86
$60.86
$45.99
$60.86 avg
$68.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.74M | 5.55M | 242.81M |
| Net Income | -97,370,957 | -55,629,950 | 41.01M |
| Profit Margin | -1,115.3% | -1,059.5% | 16.9% |
| EBITDA | -104,540,247 | -63,044,013 | 60.77M |
| Free Cash Flow | — | — | 46.40M |
| Rev Growth | +57.5% | +57.5% | -6.9% |
| Debt/Equity | 0.20 | 0.20 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |